Clinical Trials Directory

Trials / Unknown

UnknownNCT03346655

Brain Metastases in Norway - A Prospective Cohort Study

Brain Metastases in Norway - Improved Classification and Treatment. A Prospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall aim and primary outcome of this study will be a descriptive analysis of the current treatment practice of BM in Norway. Specifically, it may give answers to the following research questions: * What is the true incidence of BM in Norway? * How are patients with BM treated at present? * Do treatments differ between hospitals? * How do treatments impact quality of life of the patients? * Which factors (treatment, tumor and host variables) can explain disease control, survival, symptom relief, and general functions? * How can BM staging be improved?

Conditions

Timeline

Start date
2018-01-01
Primary completion
2022-03-31
Completion
2024-11-01
First posted
2017-11-17
Last updated
2023-11-03

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03346655. Inclusion in this directory is not an endorsement.

Brain Metastases in Norway - A Prospective Cohort Study (NCT03346655) · Clinical Trials Directory